insights_auto
Pse është ulur ALMKT 2,74%?
Zhytu më thellëchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
arrow_downward
-2,74%(-0,0026) 1D
12 nĂ«n, 5:35:12 m.d., GMT+1 · EUR
search
TĂ« gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për ALMKT...
Hap
0,10 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
19,00Â mln
VĂ«llimi mesatar
545,11 mijë
VĂ«llimi
189,93 mijë
Raporti çmim/fitim
0,79
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26Â mln
Numri i punonjësve
56
Hap
0,10 €
I lartë
0,10 €
I ulët
0,09 €
Kapitalizimi i tregut
19,00Â mln
VĂ«llimi mesatar
545,11 mijë
VĂ«llimi
189,93 mijë
Raporti çmim/fitim
0,79
Maksimumi 52-javor
0,23 €
Minimumi 52-javor
0,07 €
Fitimet për aksion
0,12 €
Aksionet në qarkullim
195,26Â mln
Numri i punonjësve
56
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
FinancialContent
·
1 orë më parë
Kaplan Fox Notifies Investors of Millrose Properties, Inc. (NYSE: MRP) of the Lead Plaintiff Deadline on December 8, 2026
Foreign Policy Journal
·
46 minuta më parë
Rocket Lab's (NASDAQ: RKLB) $3.57 Billion Backlog And Neutron Surge Keep Analysts Firmly In Buy Territory
kalkine.ca
·
35 minuta më parë
Which of the Top 5 Healthcare Names on November 12 Carries the Firmest Data or Fundamentals: enGene (NASDAQ:ENGN), Cumberland Pharmaceuticals (NASDAQ:CPIX), Jin Medical International (NASDAQ:ZJYL), Estrella Immunopharma (NASDAQ:ESL
Yahoo Finance
·
24 minuta më parë
The S&P 500 Is Hiding a Sneaky Risk. Here's How Investors Can Prepare for Potential Volatility.
Profili
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Rreth Mauna Kea Technologies SA
Drejtori ekzekutivSacha Loiseau
Punonjësit56
Themeluar më2000
Selia-
SektoriHealth Care
IndustriaMedical device
Uebsajtimaunakeatech.com